4 Hyperlipidaemia and renal disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Akmal, 1990, Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure, Kidney International, 37, 854, 10.1038/ki.1990.58
Alexander, 1974, Increased incidence of coronary heart disease associated with combined elevation of serum triglyceride and cholesterol concentrations in the nephrotic syndrome in man, Medical Journal of Australia, ii, 119, 10.5694/j.1326-5377.1974.tb93641.x
Ames, 1983, Metabolic disturbances increasing the risk of coronary heart disease during diuretic based antihypertensive therapy: lipid alterations and glucose intolerance, American Heart Journal, 106, 1207, 10.1016/0002-8703(83)90176-X
Appel, 1985, The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure and viscosity, New England Journal of Medicine, 312, 1544, 10.1056/NEJM198506133122404
Attman, 1987, Serum apolipoprotein profile of patients with chronic renal failure, Kidney International, 32, 368, 10.1038/ki.1987.219
Bagdade, 1970, Uraemic lipaemia, 126, 875
Bagdade, 1977, Plasma high density lipoprotein concentrations in chronic hemodialysis and renal transplant patients, New England Journal of Medicine, 296, 1436, 10.1056/NEJM197706232962504
Bagdade, 1968, Hypertriglyceridemia: a metabolic consequence of chronic renal failure, New England Journal of Medicine, 279, 181, 10.1056/NEJM196807252790403
Bagdade, 1976, Effects of chronic uraemia, haemodialysis and renal transplantation on plasma lipids and lipoproteins in man, Journal of Laboratory and Clinical Medicine, 87, 37
Barcelli, 1985, Is there a role for polyunsaturated fatty acids in the prevention of renal disease and renal failure?, Nephron, 41, 209, 10.1159/000183584
Baxter, 1960, Serum lipid and lipoprotein alterations in nephrosis, Journal of Clinical Investigation, 39, 455, 10.1172/JCI104058
Baxter, 1961, Effects of infusions of serum albumin on serum lipids and lipoproteins in nephrosis, Journal of Clinical Investigation, 40, 490, 10.1172/JCI104276
Beaumont, 1975, Normal serum lipids in renal transplant recipients, Lancet, i, 599, 10.1016/S0140-6736(75)91882-6
Bergstrom, 1986, Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control, Clinical Nephrology, 25, 1
Berlyne, 1969, Ischaemic heart disease as a complication of nephrotic syndrome, Lancet, ii, 399, 10.1016/S0140-6736(69)90110-X
Bhatnagar, 1989, Borderline hypercholesterolaemia: when to introduce drugs, Postgraduate Medical Journal, 65, 543, 10.1136/pgmj.65.766.543
Bilheimer, 1983, Mevinolin and colestipol stimulate receptor mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes, 80, 4124
Bilo, 1990, Fish oil in chronic renal insufficiency: positive effects on rheology, variable effects on lipid profile, Kidney International, 37, 499
Bories, 1982, Lecithin cholesterol acyl transferase activities in dialysed and undialysed chronic uraemic patients, Nephron, 32, 22, 10.1159/000182726
Bridgeman, 1972, Complications during clofibrate treatment of nephrotic syndrome hyperlipoproteinaemia, Lancet, ii, 506, 10.1016/S0140-6736(72)91905-8
Bright, 1836, Cases and observations illustrative of renal disease accompanied with the secretion of albuminous urine, Guy's Hospital Reports, 1, 338
Brunzell, 1977, Prevalence of serum lipid abnormalities in chronic haemodialysis, Metabolism, 26, 903, 10.1016/0026-0495(77)90009-9
Burton, 1971, National registry of long term dialysis patients, Journal of the American Medical Association, 218, 718, 10.1001/jama.1971.03190180040008
Cattran, 1983, The significance of lipid abnormalities in patients receiving dialysis therapy, Peritoneal Dialysis Bulletin, S29, 10.1177/089686088300303S10
Cattran, 1976, Defective triglyceride removal in lipaemia associated with peritoneal dialysis and haemodialysis, Annals of Internal Medicine, 85, 29, 10.7326/0003-4819-85-1-29
Cattran, 1979, Hyperlipidaemia after renal transplantation, Annals of Internal Medicine, 91, 554, 10.7326/0003-4819-91-4-554
Cattran, 1980, Dialysis hyperlipaemia: response to dietary manipulation, Clinical Nephrology, 13, 177
Chan, 1989, Gemfibrozil improve abnormalities of lipid metabolism in patients on CAPD, Metabolism, 38, 939, 10.1016/0026-0495(89)90003-6
Chan, 1981, Lipid abnormalities in uremia, dialysis and transplantation, Kidney International, 19, 625, 10.1038/ki.1981.62
Chan, 1982, Plasma lecithin cholesterol acyl transferase activity in uraemic patients, Clinica Chimica Acta, 119, 65, 10.1016/0009-8981(82)90405-3
Chan, 1982, Plasma LCAT activities in renal allograft recipients, Clinica Chimica Acta, 124, 187, 10.1016/0009-8981(82)90386-2
Chan, 1982, Hyperlipidaemia in patients on maintenance hemo- and peritoneal dialysis, Clinical Nephrology, 17, 183
Chanutin, 1932, Experimental renal insufficiency produced by partial nephrectomy, Archives of Internal Medicine, 39, 707
Chopra, 1971, Hyperlipoproteinaemias in nephrotic syndrome, Lancet, i, 317, 10.1016/S0140-6736(71)91044-0
Christison, 1830, On the cause of the milky and whey-like appearances sometimes observed in the blood, Edinburgh Medical Journal, 33, 274
Cohen, 1980, The mechanism of hyperlipidaemia in nephrotic syndrome: role of low albumin and the LCAT reaction, Clinica Chimica Acta, 104, 393, 10.1016/0009-8981(80)90398-8
1974, Treatment of hypertriglyceridemia, 251, 1196
Crawford, 1979, Heparin released plasma lipases in chronic renal failure and after transplantation, Clinical Science, 57, 155, 10.1042/cs0570155
Dahlen, 1975, La(a) lipoprotein/pre-beta lipoprotein in Swedish middle aged males and in patients with coronary heart disease, Clinical Genetics, 7, 334, 10.1111/j.1399-0004.1975.tb00338.x
Daniels, 1925, Plasma lipoids in renal disease, British Journal of Experimental Pathology, 6, 283
Davis, 1980, Very low density lipoprotein secretion by cultured rat hepatocytes, Journal of Biological Chemistry, 255, 2039, 10.1016/S0021-9258(19)85989-6
Davison, 1984, The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults, Clinical Nephrology, 22, 61
Dieplinger, 1986, Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by haemodialysis or peritoneal dialysis, Journal of Clinical Investigation, 77, 1071, 10.1172/JCI112406
Dombeck, 1973, Lipid metabolism in uremia and the effects of dialysate glucose and oral androgen therapy, Transactions of the American Society for Artificial Internal Organs, 19, 150, 10.1097/00002480-197301900-00027
Drueke, 1983, Recent advances in factors that alter lipid metabolism in chronic renal failure, Kidney International, 24, S134
Durrington, 1989, Hyperlipidaemia
Durrington, 1990, Secondary hyperlipidaemia, British Medical Bulletin, 10.1093/oxfordjournals.bmb.a072438
Durrington, 1985, Short term effects of beta adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men, Clinical Science, 69, 713, 10.1042/cs0690713
Duval, 1989, Influence of end stage renal failure on concentration of free apolipoprotein AI in serum, Clinical Chemistry, 35, 963, 10.1093/clinchem/35.6.963
Eisalo, 1976, Hypolipidaemic action of gemfibrozil in adult nephrotics, 69, 47
El-Nahas, 1984, Selective effect of low protein diets in chronic renal diseases, British Medical Journal, 289, 1337, 10.1136/bmj.289.6455.1337
Emmanouel, 1981, Metabolic and endocrine abnormalities in chronic renal failure, 46
Epstein, 1917, The nature and treatment of chronic parenchymatous nephritis (nephrosis), Journal of the American Medical Association, 69, 444, 10.1001/jama.1917.02590330028009
Ettinger, 1987, Lipoprotein lipid abnormalities in healthy renal transplant recipients: persistence of low HDL2 cholesterol, Nephron, 47, 17, 10.1159/000184450
Felts, 1974, Urinary loss of plasma high density lipoprotein. A possible cause of the hyperlipidaemia of the nephrotic syndrome, Circulation, 50, 263
Fidge, 1980, Turnover of apoproteins AI and AII of HDL and the relationship to other lipoproteins in normal and hyperlipidaemic individuals, Metabolism, 29, 643, 10.1016/0026-0495(80)90109-2
Frank, 1977, Uremic hyperlipoproteinemia correlation with residual renal function and duration of maintenance hemodialysis, Transactions of the American Society for Artificial Internal Organs, 23, 59, 10.1097/00002480-197700230-00018
Frick, 1987, Helsinki Heart Study, New England Journal of Medicine, 317, 1237, 10.1056/NEJM198711123172001
Fuh, 1990, Effect of chronic renal failure on high density lipoprotein kinetics, Kidney International, 37, 1295, 10.1038/ki.1990.114
Furukawa, 1990, Catabolic defect of triglyceride is associated with abnormal VLDL in experimental nephrosis, Metabolism, 39, 101, 10.1016/0026-0495(90)90155-6
Galla, 1981, Effect of prednisolone dose spacing on plasma lipids, Journal of Laboratory and Clinical Medicine, 95, 801
Gebhardt, 1984, The immunochemical determination of apolipoprotein A, total apolipoprotein AI and free apolipoprotein AI in serum of patients on chronic haemodialysis, Annals of Clinical Biochemistry, 21, 301, 10.1177/000456328402100412
Gilboa, 1976, Incidence of coronary heart disease associated with nephrotic syndrome in man, Medical Journal of Australia, i, 207, 10.5694/j.1326-5377.1976.tb140529.x
Gjone, 1981, Familial lecithin: cholesterol acyltransferase deficiency—a new metabolic disease with renal involvement, Advances in Nephrology, 10, 167
Glass, 1983, Tissue sites of degradation of apoprotein AI in the rat, Journal of Biological Chemistry, 258, 7161, 10.1016/S0021-9258(18)32346-9
Gofman, 1954, Hyperlipoproteinemia, American Journal of Medicine, 17, 514, 10.1016/0002-9343(54)90126-6
Gokal, 1979, Hyperlipidaemia following renal transplantation, Quarterly Journal of Medicine, 192, 507
Golper, 1989, Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria, American Journal of Kidney Diseases, 13, 312, 10.1016/S0272-6386(89)80038-1
Groggel, 1989, Treatment of nephrotic hyperlipoproteinaemia with gemfibrozil, Kidney International, 36, 266, 10.1038/ki.1989.189
Grundy, 1990, Management of hyperlipidaemia of kidney disease, Kidney International, 37, 847, 10.1038/ki.1990.57
Grutzmacher, 1988, Lipoproteins and apolipoproteins during the progression of chronic renal disease, Nephron, 50, 103, 10.1159/000185138
Guarneri, 1978, Lecithin-cholesterol acyltransferase (LCAT) activity in chronic uraemia, Kidney International, 13, 26
Haire, 1978, Smoking, hypertension and mortality in a maintenance dialysis population, Cardiovascular Medicine, 3, 1163
Harris, 1986, Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients, British Medical Journal, 292, 16, 10.1136/bmj.292.6512.16
Henning, 1977, Lipid metabolism in uraemia: effect of regular haemofiltration and haemodialysis, Journal of Dialysis, 1, 595, 10.3109/08860227709037655
Heuck, 1978, Hyperlipoproteinaemia in experimental chronic renal insufficiency in the rat, Kidney International, 14, 142, 10.1038/ki.1978.101
Hostetter, 1987, Progressive renal disease: is the slippery slope species specific?, Journal of Laboratory and Clinical Medicine, 109, 375
Hostetter, 1981, Hyperfiltration in remnant nephrosis: a potentially adverse response to renal ablation, American Journal of Physiology, 241, F85
Hulley, 1980, Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease, New England Journal of Medicine, 302, 1383, 10.1056/NEJM198006193022503
Huttunen, 1978, Lipoprotein metabolism in patients with chronic uraemia, Acta Medica Scandinavica, 204, 211, 10.1111/j.0954-6820.1978.tb08426.x
Ibels, 1974, Deaths from occlusive arterial disease in renal allograft recipients, British Medical Journal, 3, 552, 10.1136/bmj.3.5930.552
Ibels, 1975, Studies on the nature and causes of hyperlipiaemia in uraemia, maintenance dialysis and renal transplantation, Quarterly Journal of Medicine, 24, 601
Ibels, 1976, Plasma post-heparin lipolytic activity and triglyceride clearance in uraemic and haemodialysis patients and renal allograft recipients, Journal of Laboratory and Clinical Medicine, 87, 648
Ibels, 1977, Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients, Quarterly Journal of Medicine, 46, 197
Ibels, 1978, Hyperlipidemia in adult, paediatric and diabetic renal transplant recipients, American Journal of Medicine, 64, 634, 10.1016/0002-9343(78)90584-3
Ibels, 1978, Preservation of function in experimental renal disease by dietary restriction of phosphate, New England Journal of Medicine, 298, 122, 10.1056/NEJM197801192980302
Iida, 1987, Effect of probucol on hyperlipidaemia in patients with nephrotic syndrome, Nephron, 47, 280, 10.1159/000184524
Joven, 1987, High density lipoproteins in untreated idiopathic nephrotic syndrome without renal failure, Nephrology, Dialysis, Transplantation, 2, 149
Jungst, 1987, Relation of hyperlipidaemia in serum and loss of high density lipoproteins in urine in the nephrotic syndrome, Clinica Chimica Acta, 168, 159, 10.1016/0009-8981(87)90285-3
Kagan, 1990, Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma levels, Kidney International, 37, 980, 10.1038/ki.1990.74
Kashyap, 1980, Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome, Atherosclerosis, 35, 29, 10.1016/0021-9150(80)90025-8
Kasiske, 1987, Relationship between vascular disease and age associated changes in the human kidney, Kidney International, 31, 1153, 10.1038/ki.1987.122
Kasiske, 1985, Glomerular sclerosis in patients with massive obesity, American Journal of Nephrology, 5, 45, 10.1159/000166902
Kasiske, 1987, Persistent hyperlipidaemia in renal transplant patients, Medicine (Baltimore), 66, 309, 10.1097/00005792-198707000-00003
Kasiske, 1988, Treatment of hyperlipidaemia reduces glomerular injury in obese Zucker rats, Kidney International, 33, 667, 10.1038/ki.1988.51
Kasiske, 1990, Renal injury of diet induced hypercholesterolaemia in rats, Kidney International, 37, 880, 10.1038/ki.1990.62
Kasiske, 1990, The effects of lovastatin in hyperlipidemic patients with the nephrotic syndrome, American Journal of Kidney Diseases, 15, 8, 10.1016/S0272-6386(12)80586-5
Kasiske, 1990, Lovastatin treatment of hypercholesteraemia in renal transplant recipients, Transplantation, 49, 95, 10.1097/00007890-199001000-00021
Keane, 1987, The role of lipids in progressive glomerular disease, Advances in Experimental Medicine and Biology, 223, 81, 10.1007/978-1-4684-5445-1_11
Keane, 1988, Hyperlipidemia and the progression of renal disease, American Journal of Clinical Nutrition, 47, 157, 10.1093/ajcn/47.1.157
Kekki, 1971, Plasma triglyceride metabolism in the adult nephrotic syndrome, European Journal of Clinical Investigation, 1, 345, 10.1111/j.1365-2362.1971.tb00641.x
Kenner, 1985, Effect of protein intake on renal function and structure in partially nephrectomized rats, Kidney International, 27, 739, 10.1038/ki.1985.74
Lacour, 1982, Parathyroid function and lipid metabolism in the rat, Mineral and Electrolyte Metabolism, 7, 157
Lazarus, 1975, Cardiovascular disease in uraemia or haemodialysis, Kidney International, 7, 167
Lempert, 1988, Effects of dietary fish oil on serum lipids and blood coagulation in peritoneal dialysis patients, American Journal of Kidney Diseases, 11, 170, 10.1016/S0272-6386(88)80207-5
Lewis, 1973, Lipid abnormalities in alcoholism and chronic renal failure, 155
Linder, 1974, Accelerated atherosclerosis in prolonged maintenance haemodialysis, New England Journal of Medicine, 290, 697, 10.1056/NEJM197403282901301
Lipid Research Clinics Coronary Primary Prevention Trial Results II, 1984, The relationship of reduction in incidence of coronary heart disease to cholesterol lowering, Journal of the American Medical Association, 251, 365, 10.1001/jama.1984.03340270043026
Ljunghall, 1978, Glucose and lipoprotein metabolism in primary hyperparathyroidism: effects of parathyroidectomy, Acta Endocrinologica, 89, 580, 10.1530/acta.0.0890580
Llach, 1985, Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome, Kidney International, 28, 429, 10.1038/ki.1985.149
Lopes-Virella, 1979, Urinary HDL in minimal change disease and chronic glomerulopathies, Clinica Chimica Acta, 94, 73, 10.1016/0009-8981(79)90187-6
Losowsky, 1968, Lipid metabolism in acute and chronic renal failure, Journal of Laboratory and Clinical Medicine, 71, 736
MacTier, 1986, The natural history of membranous nephropathy in the west of Scotland, Quarterly Journal of Medicine, 60, 793
McKenzie, 1968, Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome, Journal of Clinical Investigation, 47, 1685, 10.1172/JCI105859
McLean, 1987, cDNA sequence of human apolipoprotein(a) is homologous to plasminogen, Nature, 300, 132, 10.1038/330132a0
McLeod, 1984, Plasma lipoproteins and lecithin: cholesterol acyltransferase distribution in patients on dialysis, Kidney International, 25, 683, 10.1038/ki.1984.74
Mallick, 1981, The nephrotic syndrome and ischaemic heart disease, Nephron, 27, 54, 10.1159/000182024
Manninen, 1982, Gemfibrozil treatment of dyslipidaemia in renal failure with uraemia or in the nephrotic syndrome, Research and Clinical Forums, 4, 113
Marsh, 1979, Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis, Journal of Clinical Investigation, 64, 1229, 10.1172/JCI109577
Masramon, 1975, Hyperlipidaemia after renal transplantation, Lancet, i, 1090
MBewu, 1990, Lipoprotein(a): structure, properties and possible involvement in thrombogenesis and atherogenesis, Atherosclerosis, 10.1016/0021-9150(90)90177-K
Mendez, 1990, Modification of ASCVD risk factors in transplant recipients, Kidney International, 37, 607
de Mendoza, 1976, High density lipoproteinuria in nephrotic syndrome, Metabolism, 25, 1143, 10.1016/0026-0495(76)90022-6
Miles, 1989, A potential basis for the thrombotic risks associated with lipoprotein(a), Nature, 329, 301, 10.1038/339301a0
Miyata, 1987, Effect of hyperlipidaemia on glomerular sclerosis in unilateral nephrectomized rats, Acta Pathologica Japonica, 37, 1433, 10.1111/j.1440-1827.1987.tb02265.x
Mol, 1986, Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia, Lancet, ii, 936, 10.1016/S0140-6736(86)90598-2
Moore, 1990, The effect of the American Heart Association step one diet on hyperlipidaemia following renal transplantation, Transplantation, 49, 60, 10.1097/00007890-199001000-00013
Moorhead, 1982, Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease, Lancet, ii, 1309, 10.1016/S0140-6736(82)91513-6
Mordasini, 1977, Selective deficiency of hepatic triglyceride lipase in uraemic patients, New England Journal of Medicine, 297, 1362, 10.1056/NEJM197712222972502
Mordasini, 1982, Pathogenetic aspects of hyperlipoproteinaemia in chronic renal disorders, 317
Muls, 1985, Lipid distribution and composition in the human nephrotic syndrome, Atherosclerosis, 54, 225, 10.1016/0021-9150(85)90181-9
Murase, 1975, Inhibition of lipoprotein lipase by uraemic plasma: a possible cause of hypertriglyceridaemia, Metabolism, 24, 1279, 10.1016/0026-0495(75)90066-9
Nayak, 1990, Serum apolipoproteins A and B, LCAT activities and urinary cholesterol levels in nephrotic syndrome patients before and during steroid treatment, Nephron, 54, 234, 10.1159/000185861
Neary, 1988, The effect of renal failure and haemodialysis on the concentrations of free apolipoprotein AI in the serum and the implications for the catabolism of high density lipoproteins, Clinica Chimica Acta, 171, 239, 10.1016/0009-8981(88)90149-0
Nestel, 1982, Increased lipoprotein remnant formation in chronic renal failure, New England Journal of Medicine, 307, 329, 10.1056/NEJM198208053070601
Newark, 1975, Lipoprotein profiles in adult nephrotics, 50, 359
Nicholls, 1980, Accelerated atherosclerosis in long term dialysis and renal transplant patients: fact or fiction?, Lancet, i, 276, 10.1016/S0140-6736(80)90777-1
Nikkila, 1976, Gemfibrozil: effects of serum lipids, lipoproteins, post-heparin plasma lipase activities and glucose intolerance in primary hypertriglyceridaemia, 69, 58
Nilsson-Ehle, 1980, Lipolytic enzymes and plasma lipoprotein metabolism, Annual Review of Biochemistry, 49, 667, 10.1146/annurev.bi.49.070180.003315
Norbeck, 1980, Increased frequency of late pre-beta lipoproteins in isolated serum VLDL in uraemia, European Journal of Clinical Investigation, 10, 423, 10.1111/j.1365-2362.1980.tb02079.x
Oetliker, 1980, Lipoprotein metabolism in nephrotic syndrome in childhood, Pediatric Research, 14, 64
Ordonez, 1989, The risk of coronary artery disease among patients with the nephrotic syndrome, 55
Pasternack, 1987, Normalization of lipoprotein lipase and hepatic lipase by gemfibrozil results in correction of lipoprotein abnormalities in chronic renal failure, Clinical Nephrology, 27, 163
Pierides, 1975, Clofibrate-induced muscle damage in patients with chronic renal failure, Lancet, ii, 1279, 10.1016/S0140-6736(75)90613-3
Ponticelli, 1978, Lipid disorders in renal transplant recipients, Nephron, 20, 189, 10.1159/000181221
Querfeld, 1988, Lipoprotein profiles at different stages of the nephrotic syndrome, European Journal of Pediatrics, 147, 233, 10.1007/BF00442685
Rabelink, 1988, Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome, Lancet, ii, 1335, 10.1016/S0140-6736(88)90870-7
Raine, 1984, Cardiovascular complications after renal transplantation, 439
Raine, 1987, Increased plasma LDL cholesterol after renal transplantation associated with cyclosporin immunosuppression, 19, 1820
Raine, 1988, Adverse effect of cyclosporin on plasma cholesterol in renal transplant recipients, Nephrology, Dialysis, Transplantation, 3, 458, 10.1093/oxfordjournals.ndt.a091698
Rapoport, 1978, Defective high density lipoprotein composition in patients on chronic hemodialysis, New England Journal of Medicine, 299, 1326, 10.1056/NEJM197812142992402
Reaven, 1980, An inquiry into the mechanism of hypertriglyceridemia in patients with chronic renal failure, American Journal of Clinical Nutrition, 33, 1476, 10.1093/ajcn/33.7.1476
Robert, 1989, Changes in lipoproteins induced by the remnant kidney tissue or binephrectomy in chronic uraemic patients treated by haemodialysis, Metabolism, 38, 514, 10.1016/0026-0495(89)90210-2
Rosenmann, 1957, Relationship between concentrations of albumin and lipids in plasma of experimentally nephrotic rats, Journal of Clinical Investigation, 36, 700
Rosman, 1984, Prospective randomized trial of early dietary protein restriction in chronic renal failure, Lancet, ii, 1291, 10.1016/S0140-6736(84)90818-3
Rostand, 1979, Ischemic heart disease in patients with uremia undergoing maintenance dialysis, Kidney International, 16, 600, 10.1038/ki.1979.170
Saku, 1988, High density lipoprotein apolipoprotein AI and AII turnover in moderate and severe proteinuria, Nephron, 50, 112, 10.1159/000185139
Sanfelippo, 1977, Reduction of plasma triglycerides by diet in subjects with chronic renal failure, Kidney International, 11, 54, 10.1038/ki.1977.7
Sanfelippo, 1978, Response of plasma triglycerides to dietary changes in patients on hemodialysis, Kidney International, 14, 180, 10.1038/ki.1978.105
Santo, 1979, Glucose utilization from dialysate in patients on CAPD, International Journal of Artificial Organs, 2, 119
Savdie, 1979, High density lipoprotein in chronic renal failure and after renal transplantation, British Medical Journal, i, 928, 10.1136/bmj.1.6168.928
Savdie, 1980, Impaired plasma triglyceride clearance as a feature of both uremia and post-transplant triglyceridemia, Kidney International, 18, 774, 10.1038/ki.1980.196
Schaefer, 1978, Chronic hemofiltration: a critical evaluation of a new method for the treatment of blood, Artificial Organs, 2, 386, 10.1111/j.1525-1594.1978.tb01628.x
Schorn, 1988, Long term immunosuppressive therapy and lipid abnormalities in renal transplant recipients, Nephrology, Dialysis, Transplantation, 3, 581
Scott, 1970, Low density lipoprotein peptide metabolism in nephrotic syndrome, Australian Annals of Medicine, 1, 1
Segal, 1979, Apoprotein of high density lipoproteins in the urine of normal subjects, Lipid Research, 20, 784, 10.1016/S0022-2275(20)40031-8
Shepard, 1980, Cholestyramine promotes receptor mediated low density lipoprotein catabolism, New England Journal of Medicine, 302, 1219, 10.1056/NEJM198005293022202
Shetty, 1990, Adverse effects of hypolipidaemic drugs, Adverse Drug Reaction Bulletin No 142, 532
Shore, 1982, Serum and urine lipoproteins in the human nephrotic syndrome: evidence for renal catabolism of lipoproteins, Metabolism, 31, 258, 10.1016/0026-0495(82)90062-2
Short, 1986, Serum and urinary high density lipoproteins in glomerular disease with proteinuria, Kidney International, 29, 1224, 10.1038/ki.1986.131
Short, 1990, Raised apolipoprotein(a) levels may be a contributory factor in the thrombotic tendency of membranous nephropathy
Sniderman, 1987, Hyperapobetalipoproteinaemia; the major dyslipoproteinaemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis, Atherosclerosis, 65, 257, 10.1016/0021-9150(87)90041-4
Sokolovskaya, 1984, High density lipoprotein cholesterol in patients with untreated and treated nephrotic syndrome, Nephron, 37, 49, 10.1159/000183207
Steele, 1989, Lipids, lipoproteins and apolipoproteins AI and B and apolipoprotein losses in CAPD, Atherosclerosis, 79, 47, 10.1016/0021-9150(89)90032-4
Steger, 1990, Decreased lipoprotein lipase activity in hyperlipidemic renal transplant recipients immunosuppressed with cyclosporin A, Kidney International, 37, 613
Steinberg, 1988, Metabolism of lipoproteins and their role in the pathogenesis of atherosclerosis, vol. 18, 1
Swamy, 1977, Dialysate glucose and hyperlipidaemia, Dialysis and Transplantation, 6, 52
Thomas, 1976, Factors in the different rate of arteriosclerosis between long surviving renal transplant recipients and dialysis patients, Annals of Surgery, 184, 342, 10.1097/00000658-197609000-00012
Valeri, 1986, Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial, American Journal of Kidney Diseases, 8, 388, 10.1016/S0272-6386(86)80164-0
van Acker, 1987, The effect of fish oil on lipid profiles and viscosity of erythrocyte suspensions in CAPD patients, Nephrology, Dialysis, Transplantation, 2, 557
Vosnides, 1974, Hyperlipidaemia in renal disease, Medical Journal of Australia, ii, 855
Waldmann, 1964, Studies on the metabolism of serum proteins and lipids in a patient with analbuminemia, American Journal of Medicine, 37, 960, 10.1016/0002-9343(64)90136-6
Wanner, 1990, Effect of lovastatin on the lipoprotein system of hyperlipidemic hemodialysis patients, Kidney International, 37, 323
Warwick, 1990, Low density lipoprotein metabolism in the nephrotic syndrome, Metabolism, 39, 187, 10.1016/0026-0495(90)90074-M
Wass, 1981, Cardiovascular disease and the nephrotic syndrome, the other side of the coin, Nephron, 27, 58, 10.1159/000182025
Wass, 1979, Does the nephrotic syndrome increase the risk of cardiovascular disease?, Lancet, ii, 664, 10.1016/S0140-6736(79)92067-1
Wing, 1978, Combined report on regular dialysis and transplantation in Europe, 15, 4
Wing, 1984, Cardiovascular-related causes of death and the fate of patients with cardiovascular disease, Contributions to Nephrology, 41, 306, 10.1159/000429302
Yamada, 1970, Lipoprotein lipase in clinical and experimental nephrosis, Clinica Chimica Acta, 30, 787, 10.1016/0009-8981(70)90276-7
Yedgar, 1982, Viscosity of culture medium as a regulator of synthesis and secretion of very low density lipoproteins by cultured hepatocytes, Journal of Biological Chemistry, 257, 2188, 10.1016/S0021-9258(18)34904-4